Eunethydis

EUropean NETwork for HYperkinetic DISorders

[Alessio Bellato @AlessioBellato]

@eunethydis is also on Linkedin now!
https://t.co/KG8Cp3FLP1

[Eunethydis @eunethydis]

Our next #Eunethydiswebinar will be given by Dr. Johan Isaksson! The webinar is open for all - please register in advance using the link below👇!
https://t.co/IicM7OBzTJ

[Dave Coghill @dave_coghill]

Great to finally launch our ADHD Prescribing guide
Ritalin is often first choice for ADHD – but a new guide says there’s no one-size-fits-all https://t.co/drwOIgDl88

[Samuele Cortese @CorteseSamuele]

Our network meta-analysis (NMA), led by the amazing @luis_farhat, on the pharmacological treatment of #ADHD comorbid with #Tourette disorder
https://t.co/ixVdRi7hRs

[Eunethydis @eunethydis]

@StephenFaraone

[Eunethydis @eunethydis]

Our next #Eunethydiswebinar will be given by Dr. Peter Nagy! The webinar is open for all - please register in advance using the link below👇!
https://t.co/DMfLo8tju1

[Eunethydis @eunethydis]

Here is a reminder of our next webinar on next Tuesday (10 September)! Please ensure to register in advance using the link below!

[Eunethydis @eunethydis]

Our next #Eunethydiswebinar will be given by Dr. Peter Nagy! The webinar is open for all - please register in advance using the link below👇!
https://t.co/DMfLo8tju1

[Professor Kapil Sayal 💙 CYPMHSResearch @CYPMHSResearch]

Youngest children in school year more commonly diagnosed with, & prescribed medication for #ADHD, than older classmates

#RelativeAge effect associated with #ADHD & #ASD diagnosis receipt

Great new systematic review led by @EleanaFrisira @Drjoholland. 👉 https://t.co/fctFNkOSoH

[Samuele Cortese @CorteseSamuele]

#ADHD and #HEALTH CONDITIONS
https://t.co/J2yPyr0ifa

[Eunethydis @eunethydis]

Our next webinar will be given by Dr. Maite Ferrin! The webinar is open for all - please register in advance using the link below or scanning the QR code👇👇!
https://t.co/jxkHaJHCzz

[Dr Anna Price @Anna_M_Price]

Pleased to see findings from the MAP study in print ⏩https://t.co/lxuhaBqoiH
Thanks to the healthcare professionals, people with lived experience of #ADHD, @ukaan_org & @ADHDFoundation for supporting this research 🙏
@ChYMe_Exe @UoEAPEx @NIHRSPCR @UniofExeter

[Samuele Cortese @CorteseSamuele]

@RcpsychCAP @SotonPsych @eunethydis @CADDRA_News @APSARD @ADHD_Europe

[Samuele Cortese @CorteseSamuele]

@RcpsychCAP @rcpsych @SotonPsych @unisouthampton @UoS_Medicine @eunethydis @CADDRA_News @ADHD_Europe @APSARD

[Samuele Cortese @CorteseSamuele]

Protocol of our trial on #trigeminal #nerve #stimulaiton for #ADHD, led by @KatyaRubia108

Fantastic team of very committed colleagues- watch the space !

Still open for recruitment: more info at : https://t.co/NfJzQ7IUxU

[ADHD Congress | Modernising the concept of ADHD @ADHD_Congress]

#WFADHD's International Consensus Statement on ADHD, combating misconceptions and stigma, is available in 12 languages, now incl. #Romanian! Thanks to A. Hodorog from @cardiffuni. A pivotal moment in our mission to support those with #ADHD. 🌍 https://t.co/uMnGtpAuGg @aboutadhdro

[Samuele Cortese @CorteseSamuele]

In the spirit of #openscience, the database of randomised controlled trials (#RCTs) of #ADHD medications that we used for our 2018 network meta-analysis (https://t.co/UONj56Alkn), updated since then, can be freely accessed. Find out how here: https://t.co/mIZW3OU7vm

[Inspire the Mind ✍🧠 @inspirethemind_]

What does the transition to #adulthood look like for individuals with #ADHD? Prof Jonna Kuntsi talks about the ADHD Remote Technology research programme:

@ADHD_RemoteTech @KingsIoPPN

https://t.co/I0F3m4Mit0

[Eunethydis @eunethydis]

🧵2/2

[Eunethydis @eunethydis]

April 2024 #EUNETHYDIS newsletter is ready 👇👇 with the news on the network’s next meetings, homepage updates and new members welcome. 🧵1/2

[Eunethydis @eunethydis]

Please use the following link to register for the webinar:
https://t.co/oQhYXD9if1